sumi.news
Search
Following
Sign in
← Back to news
S
Seeking Alpha: News
RSS Feed
seekingalpha.com/market-news
seekingalpha.com/market_currents.xml
Follow
Latest
Sun Feb 1
Nvidia joins funding for UK's driverless startup in $103M round
7h
S
Cryoport outlines $190M–$194M 2026 revenue target as commercial cell therapy drives growth
7h
S
Superior group outlines 2026 revenue target of up to $585M with back-end weighted growth amid strategic investments
7h
S
Arcturus outlines 12-week Phase II CF trial launch and expects regulatory clarity for ARCT-810 in 2026
7h
S
QuickLogic forecasts 50%–100% revenue growth in 2026 as major government contracts and storefront initiatives accelerate
8h
S
GitLab outlines FY '27 revenue guidance of $1.099B–$1.118B while launching AI agent platform and $400M share repurchase program
9h
B
Cricut outlines accelerated product launches and bundle-first strategy as platform revenue rises 6% year-on-year
9h
B
NeuroPace reiterates $98M–$100M 2026 revenue target while advancing AI and IGE pipeline
10h
B
B&G Foods outlines $1.655B–$1.695B sales target for 2026 as portfolio transformation accelerates
10h
S
Brent crude jumps to more than one-year high as Iraq shuts down giant oil fields
11h
S
SoundThinking targets 15% ARR growth in 2026 as it strengthens sales leadership and expands SafePointe
11h
S
Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion
11h
B
Crexendo outlines path to $100M revenue run rate with ESI acquisition while accelerating AI-driven growth
12h
B
Ascent Industries targets double-digit revenue growth and mid-20s to low 30s margins for 2026 while advancing high-margin pipeline
12h
B
Exxon may be 'interested in going back' to Venezuela if conditions are right, executive says
12h
S
U.S. crude stockpiles rose 5.6M barrels last week, API says
12h
S
Dexterra Group GAAP EPS of C$0.12, revenue of C$271M
13h
S
Grupo Supervielle outlines 25%-30% loan growth target for 2026 as margins recover and capital strengthens
13h
S
Alamo Group outlines long-term 10% sales growth and 15% margin targets as portfolio shifts continue
13h
S
Here are the major earnings before the open Wednesday
13h
S
Gold bulls keep the faith despite this week's drop on surging dollar, bond yields
13h
S
Target outlines $2B incremental investment and 2% sales growth plan for 2026 while accelerating store remodels and digital expansion
13h
S
Target bets on increased capex, AI, and new stores to reverse decline
13h
S
Semtech acquires HieFo for $34M
13h
S
Everspin Technologies Q4 2025 Earnings Preview
13h
S
Verastem Q4 2025 Earnings Preview
13h
S
Smith Micro Software Q4 2025 Earnings Preview
13h
S
TriplePoint Venture Growth BDC Q4 2025 Earnings Preview
13h
S
Grocery Outlet Q4 2025 Earnings Preview
13h
S
Aquestive Therapeutics Q4 2025 Earnings Preview
13h
S
StubHub Holdings, Inc. Q4 2025 Earnings Preview
13h
S
ASM International reports Q4 results
13h
S
Moderna surges after hours on patent settlement with Arbutus and Genevant
13h
S
Rayonier Advanced Materials stock falls on quarterly results
13h
S
Clarke reports Q4 results
13h
S
Cumberland Pharmaceuticals Non-GAAP EPS of $0.11, revenue of $44.5M
13h
S
Fortitude Gold GAAP EPS of $0.02, revenue of $18.41M
13h
S
Reservoir Media says Irenic made buyout offer of $10-$11 a share
13h
S
Meta inks AI content licensing deal with News Corp. for $50M per year: report
14h
S
Oculis Holding GAAP EPS of CHF -0.42 beats by $0.11
14h
S
Nebius receives approval to build 1.2 GW 'AI factory' in Missouri
14h
S
SITE Centers announces sale of 3030 North Broadway
14h
S
Scandium Canada announces C$10 million bought deal unit offering
14h
S
Hyster-Yale Materials Handling Non-GAAP EPS of -$2.06 misses by $0.83, revenue of $923.2M beats by $6.77M
14h
S
Fitch upgrades Flagstar Bank's ratings on execution of restructuring
14h
S
CrowdStrike in charts: ARR climbs above $5B in Q4
14h
S
First Acceptance GAAP EPS of $0.24, revenue of $99.9M
14h
S
FCPT announces acquisition of national automotive service operator property for $1.6M
14h
S
Scholar Rock outlines 2026 apitegromab BLA resubmission and commercial launch following FDA progress
14h
S
Vanda granted public hearing to review FDA denying Hetlioz for jet lag
14h
S
More →